The Best Articles in Health Care
The most useful articles in Health Care from around the web—beginners to advanced—curated by thought leaders and our community. We focus on timeless pieces and update the list whenever we discover new, must-read articles or videos—make sure to bookmark and revisit this page.
Top 5 Health Care Articles
At a glance: these are the articles that have been most read, shared, and saved in Health Care by Refind users in 2023 so far.
- The FDA just approved a new treatment for Alzheimer’s. It’s a very big deal.
- AI is dreaming up drugs that no one has ever seen. Now we’ve got to see if…
- Long-sought universal flu vaccine: mRNA-based candidate enters clinical trial
- Immunologist Akiko Iwasaki: ‘We are not done with Covid, not even close’
- A New Approach to M.S. Could Transform Treatment of Other Diseases
Short Articles
Short on time? Check out these useful short articles in Health Care—all under 10 minutes.
The FDA just approved a new treatment for Alzheimer’s. It’s a very big deal.
It’s a glimmer of hope for patients and families — if the US health system can handle it.
A New Approach to M.S. Could Transform Treatment of Other Diseases
Multiple sclerosis was once seen as a “dead-end disease.” But lots of little interventions have added up to remarkable progress. Should that change how we take on other conditions?
How the pandemic messed with our perception of time
A neuroscientist explains how history, mood, and surprise can make life feel like a slog — or go by in a blur.
Immunologist Akiko Iwasaki: ‘We are not done with Covid, not even close’
The Yale professor and long Covid expert on why the virus is causing ongoing illness for so many, and the challenges she faces as a woman of colour in science
Long-sought universal flu vaccine: mRNA-based candidate enters clinical trial
The phase I trial will test safety and efficacy in a small number of people.
Long Articles
These are some of the most-read long-form articles in Health Care.
End-of-Life Dreams
“In a high-tech, evidence-driven world of contemporary medicine, it was a dream that led a physician to conclude that my wife was dying. How was that possible?”
Should we abandon the idea that cancer is something to ‘fight’?
Is it time to abandon the century-old idea that cancer is best met with a ‘fight’ from patients and their doctors alike?
AI is dreaming up drugs that no one has ever seen. Now we’ve got to see if…
AI automation throughout the drug development pipeline is opening up the possibility of faster, cheaper pharmaceuticals.
Salt, Sugar, Water, Zinc: How Scientists Learned to Treat the 20th Century’s Biggest Killer of Children—Asterisk
Oral rehydration therapy is now the standard treatment for dehydration. It’s saved millions of lives, and can be prepared at home in minutes. So why did it take so long to discover?
Long COVID Now Looks like a Neurological Disease, Helping Doctors to Focus Treatments
The causes of long COVID, which disables millions, may come together in the brain and nervous system
Thought Leaders
We monitor hundreds of thought leaders, influencers, and newsletters in Health Care, including:
Kevin Pho, M.D.
Physician | http://KevinMD.com | The Podcast by KevinMD
nature
Research, News, and Commentary from Nature, the international journal of science. For daily science news, get Nature Briefing: http://go.nature.com/naturebriefing
STAT
Reporting from the frontiers of health & medicine. Sign up for any of our 10 free newsletters here: http://statnews.com/signup
Ed Yong has left The Atlantic
Science writer. Freelance. Many words, some awards. Author: AN IMMENSE WORLD. Married to Liz Neeley. Parent to Typo. http://edyong.me http://buttondown.email/edyong209
Care Policy and Evaluation Centre
Leading research centre in long-term (social) care, mental health, developmental disability & other health issues to inform & influence global policy & practice
What is Refind?
Every day Refind picks the most relevant links from around the web for you. Picking only a handful of links means focusing on what’s relevant and useful. We favor timeless pieces—links with long shelf-lives, articles that are still relevant one month, one year, or even ten years from now. These lists of the best resources on any topic are the result of years of careful curation.
How does Refind curate?
It’s a mix of human and algorithmic curation, following a number of steps:
- We monitor 10k+ sources and 1k+ thought leaders on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
- In addition, our users save links from around the web using our Save buttons and our extensions.
- Our algorithm processes 100k+ new links every day and uses external signals to find the most relevant ones, focusing on timeless pieces.
- Our community of active users gets the most relevant links every day, tailored to their interests. They provide feedback via implicit and explicit signals: open, read, listen, share, mark as read, read later, «More/less like this», etc.
- Our algorithm uses these internal signals to refine the selection.
- In addition, we have expert curators who manually curate niche topics.
The result: lists of the best and most useful articles on hundreds of topics.
How does Refind detect «timeless» pieces?
We focus on pieces with long shelf-lives—not news. We determine «timelessness» via a number of metrics, for example, the consumption pattern of links over time.
How many sources does Refind monitor?
We monitor 10k+ content sources on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
Who are the thought leaders in Health Care?
We follow dozens of thought leaders in Health Care, including Kevin Pho, M.D., nature, STAT, Ed Yong has left The Atlantic, Care Policy and Evaluation Centre.
Missing a thought leader? Submit them here
Can I submit a link?
Indirectly, by using Refind and saving links from outside (e.g., via our extensions).
How can I report a problem?
When you’re logged-in, you can flag any link via the «More» (...) menu. You can also report problems via email to hello@refind.com
Who uses Refind?
250k+ smart people start their day with Refind. To learn something new. To get inspired. To move forward. Our apps have a 4.9/5 rating.
Is Refind free?
Yes, it’s free!
How can I sign up?
Head over to our homepage and sign up by email or with your Twitter or Google account.